Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Strong performance in surfactants, piezoelectric materials and conductive polymer agents; weak performance in fine-particle products used as cosmetic ingredients; higher depreciation expenses following the expansion of manufacturing facilities for functional fine-particle products; deterioration in the titanium dioxide business due to aggressive competition from China and elsewhere and declining domestic demand; and an impairment loss of ¥3,170 million.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥57,373 million (YoY +2.9%) |
| Operating profit | ¥2,176 million (YoY -38.3%) |
| Ordinary income | ¥2,672 million (YoY -28.7%) |
| Profit attributable to owners of the parent | ¥-878 million (YoY -136.3%) |
| Net income per share | (¥38.47) |
| Operating Margin | 3.8％ |
| Equity ratio | End of the current fiscal period 68.9％ / End of previous period 66.6％ |
| Total assets | ¥88,558 million |
| Net assets | ¥61,491 million |
| Cash flows from operating activities | ¥4,541 million |
| Cash flows from investing activities | ¥-6,213 million |
| Cash flows from financing activities | ¥-1,196 million |
| Cash and cash equivalents at end of period | ¥11,194 million |
| Full-year earnings forecast | Net Sales ¥59,500 million (YoY +3.7%) / Operating profit ¥2,500 million (YoY +14.9%) / Ordinary income ¥2,900 million (YoY +8.5%) / Net income ¥1,800 million |
| Annual Dividend Forecast | ¥60 per share → ¥80 per share（+33.3%） |
| Payout ratio | 101.5% (forecast for the fiscal year ending March 2027) |
| Shareholder Return Policy | The higher of a DOE of 3% or more and a payout ratio of 100% serves as the benchmark |
| Segment revenue | ¥26,213 million (YoY -8.0%), ¥30,007 million (YoY +14.9%), ¥1,152 million (YoY +3.0%) |
| Segment profit | ¥-606 million, ¥2,493 million, ¥278 million |
| Regional sales | ¥33,702 million, ¥9,169 million, ¥14,500 million |
| Depreciation and amortization | ¥3,609 million |
| Impairment loss | ¥3,170 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥29 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥503 million, Impairment Losses ¥3,170 million |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name None |
| Material subsequent events | Cancellation of 1,000,000 treasury shares; acquisition of treasury shares up to a maximum of 1,500,000 shares and a total acquisition cost of ¥2,500 million; and absorption-type merger of wholly owned subsidiary TFT株式会社, effective 1 April 2026 |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 23,914,414 |
| Treasury Shares at Period-End | 1,083,607 |
| Factors Behind Changes in Business Performance | Strong performance in surfactants, piezoelectric materials and conductive polymer agents; weak performance in fine-particle products used as cosmetic ingredients; higher depreciation expenses following the expansion of manufacturing facilities for functional fine-particle products; deterioration in the titanium dioxide business due to aggressive competition from China and elsewhere and declining domestic demand; and an impairment loss of ¥3,170 million. |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Electronic Materials and Chemicals business performed well in surfactants, piezoelectric materials and conductive polymer agents. In the Functional Materials business, fine-particle products used as cosmetic ingredients performed poorly, while depreciation expenses increased following the expansion of manufacturing facilities. In the titanium dioxide business, the operating environment deteriorated due to aggressive sales efforts by overseas competitors, including those in China, and declining domestic demand, resulting in the recognition of an impairment loss of ¥3,170 million.